ARCH Venture Partners

ARCH Venture Partners is a premier provider of seed and early stage venture capital for technology firms, with a special competence in co-founding and building firms from start-up.

Our mission is to deliver promising technologies from the earliest stages to successful commercial application – from concept to commerce.

With a 30 year history and $2 billion in capital under management, ARCH has secured its place among the largest providers of seed and early stage capital in the U.S.

TypeInvestor
HQChicago, IL, US
Founded1986
Websitearchventure.com
Cybersecurity ratingAMore
ARCH Venture Partners was founded in 1986 and is headquartered in Chicago, IL, US
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at ARCH Venture Partners

Kristina Burow

Kristina Burow

Managing Director
Robert Nelsen

Robert Nelsen

Co-Founder and Managing Director
Keith Crandell

Keith Crandell

Co-Founder and Managing Director
Steve Gillis

Steve Gillis

Managing Director
Clinton Bybee

Clinton Bybee

Co-founder and Managing Director, Emeritus
Jason Doren

Jason Doren

General Counsel
Show more

ARCH Venture Partners Office Locations

ARCH Venture Partners has offices in Chicago, San Francisco and Seattle
Chicago, IL, US (HQ)
8755 W Higgins Rd #1025
San Francisco, CA, US
1700 Owens St #535, San Francisco
Seattle, WA, US
188 E Blaine St #125
Show all (3)

ARCH Venture Partners Investment Portfolio

Stage Distribution

19982022

Top Sectors Distribution

19892022

Round Size Distribution

19982022
Show more

ARCH Venture Partners News and Updates

ARCH Venture Partners Announces $2.975 Billion Fund XII to Create and Fund Early Stage Biotechnology Companies

CHICAGO, June 29, 2022 /PRNewswire/ -- ARCH Venture Partners today announced the closing of ARCH Venture Fund XII, with $2.975 billion to invest in the creation, development and funding of early stage biotechnology companies. This new fund follows the January 2021 announcement of the...

ARCH Venture Partners Announces Kaye Foster as Venture Partner

CHICAGO, Jan. 12, 2022 /PRNewswire/ -- ARCH Venture Partners, one of the world's leading early-stage technology venture firms, today announced the appointment of Kaye Foster as Venture Partner. Foster is an accomplished senior human resources and talent executive with deep experience in...

Chinese drug maker SciNeuro Pharma raises $100m co-led by LAV, Arch Venture Partners

General Atlantic, and Sequoia Capital China also invested in the round. The post Chinese drug maker SciNeuro Pharma raises $100m co-led by LAV, Arch Venture Partners appeared first on DealStreetAsia.

ARCH Venture Partners Online and Social Media Presence

Embed Graph

ARCH Venture Partners Blogs

ARCH Venture Partners Announces Promotions and New Appointment

CHICAGO — ARCH Venture Partners today announced several key promotions and the appointment of Olivia Zetter as Strategic Advisor and Venture Partner. Key promotions include: • Ari Nowacek, M.D., Ph.D., to Partner • Sean Kendall to Partner, Europe • Corey Ritter to Principal • Nilay Thakar, Ph.D., to…

ARCH Venture Partners Announces Several Key Appointments

–John Maraganore, Ph.D., Jake Bauer, Luciana Borio, M.D., Axel Bouchon, Ph.D., and Sabah Oney, Ph.D., named Venture Partners– –Promotions and additions expand team’s company building capabilities–   CHICAGO – ARCH Venture Partners, one of the world’s leading early-stage technology venture firms, tod…

ARCH unveils Neumora, its Really Big Neuroscience Company, with $500M, an Amgen deal and eyes on depression, Alzheimer’s and a lot more

The post ARCH unveils Neumora, its Really Big Neuroscience Company, with $500M, an Amgen deal and eyes on depression, Alzheimer’s and a lot more appeared first on Arch Venture Partners.

ARCH-backed Dewpoint, eGenesis and Prime Medicine named to Endpoints 11 Most Promising Biopharma Startups in 2021

The post ARCH-backed Dewpoint, eGenesis and Prime Medicine named to Endpoints 11 Most Promising Biopharma Startups in 2021 appeared first on Arch Venture Partners.

bluebird bio and National Resilience Ink Cell Therapy Strategic Alliance

The post bluebird bio and National Resilience Ink Cell Therapy Strategic Alliance appeared first on Arch Venture Partners.

ARCH adds FDA, biodefense expertise with appointment of Luciana Borio

The post ARCH adds FDA, biodefense expertise with appointment of Luciana Borio appeared first on Arch Venture Partners.
Show more

ARCH Venture Partners Frequently Asked Questions

  • When was ARCH Venture Partners founded?

    ARCH Venture Partners was founded in 1986.

  • Who are ARCH Venture Partners key executives?

    ARCH Venture Partners's key executives are Kristina Burow, Robert Nelsen and Keith Crandell.

  • Where is ARCH Venture Partners headquarters?

    ARCH Venture Partners headquarters is located at 8755 W Higgins Rd #1025, Chicago.

  • Where are ARCH Venture Partners offices?

    ARCH Venture Partners has offices in Chicago, San Francisco and Seattle.

  • How many offices does ARCH Venture Partners have?

    ARCH Venture Partners has 3 offices.